AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
IMPROVED TOLERABILITY OF FELODIPINE COMPARED WITH AMLODIPINE IN ELDERLY HYPERTENSIVES - A RANDOMIZED, DOUBLE-BLIND-STUDY IN 535 PATIENTS, FOCUSING ON VASODILATORY ADVERSE EVENTS
Authors: SCHAEFER RM ALDONS PM BURGESS ED TILVIS R SINGH GP REHN L MORGAN TO
Citation: Rm. Schaefer et al., IMPROVED TOLERABILITY OF FELODIPINE COMPARED WITH AMLODIPINE IN ELDERLY HYPERTENSIVES - A RANDOMIZED, DOUBLE-BLIND-STUDY IN 535 PATIENTS, FOCUSING ON VASODILATORY ADVERSE EVENTS, International journal of clinical practice, 52(6), 1998, pp. 381
IRON MONITORING AND SUPPLEMENTATION - HOW DO WE ACHIEVE THE BEST RESULTS
Authors: SCHAEFER RM SCHAEFER L
Citation: Rm. Schaefer et L. Schaefer, IRON MONITORING AND SUPPLEMENTATION - HOW DO WE ACHIEVE THE BEST RESULTS, Nephrology, dialysis, transplantation, 13, 1998, pp. 9-12
DECORIN, BIGLYCAN AND THEIR ENDOCYTOSIS RECEPTOR IN RAT RENAL-CORTEX
Authors: SCHAEFER L HAUSSER H ALTENBURGER M UGORCAKOVA J AUGUST C FISHER LW SCHAEFER RM KRESSE H
Citation: L. Schaefer et al., DECORIN, BIGLYCAN AND THEIR ENDOCYTOSIS RECEPTOR IN RAT RENAL-CORTEX, Kidney international, 54(5), 1998, pp. 1529-1541
SAFETY OF 1-M GADOBUTROL AS A NEW MR CONTRAST AGENT FOR FIRST-PASS AND CONVENTIONAL INVESTIGATIONS - PHASE-III CLINICAL-TRIAL IN PATIENTS WITH CHRONICALLY IMPAIRED RENAL-FUNCTION
Authors: TOMBACH B BREMER CB SCHAEFER RM GEENS VR REIMER P
Citation: B. Tombach et al., SAFETY OF 1-M GADOBUTROL AS A NEW MR CONTRAST AGENT FOR FIRST-PASS AND CONVENTIONAL INVESTIGATIONS - PHASE-III CLINICAL-TRIAL IN PATIENTS WITH CHRONICALLY IMPAIRED RENAL-FUNCTION, Radiology, 209P, 1998, pp. 1366-1366
DISORDERS IN ACID-BASE METABOLISM
Authors: SCHAEFER RM SCHAEFER L
Citation: Rm. Schaefer et L. Schaefer, DISORDERS IN ACID-BASE METABOLISM, Der Internist, 39(8), 1998, pp. 820-824
THE LONG-TERM SAFETY OF ALPROSTADIL (PROSTAGLANDIN-E-1) IN PATIENTS WITH ERECTILE DYSFUNCTION
Authors: ALVAREZ E ANDRIANNE R ARVIS G BOEZAART F BUVAT J CZYZYK A DEBOCCARD GA DECLERCQ G DISILVERIO F DRENT D DUPREEZ M HEAL M HENRIET J JARDIN A LERICHE A LOCHNERERNST D MARTELLI A MARX W MATTARELLI G MERCKX L MEULEMAN EJH MIRONE V MORGAN J NAUDE JH NAVRATIL H NOREN S PAGANO F POMEROL JM PORST H PRYOR J SANDHU DPS SCHAEFER RM SCHMIDT A STACKL W STAEHLER G STEIN R SULKE J VANAHLEN H VADERSCHUEREN D WEISKE WH WESPES E BORG G
Citation: E. Alvarez et al., THE LONG-TERM SAFETY OF ALPROSTADIL (PROSTAGLANDIN-E-1) IN PATIENTS WITH ERECTILE DYSFUNCTION, British Journal of Urology, 82(4), 1998, pp. 538-543
DIFFERENTIAL REGULATION OF GLOMERULAR GELATINASE-B (MMP-9) AND TISSUEINHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN OBESE ZUCKER RATS
Authors: SCHAEFER L HAN X AUGUST C SCHAEFER RM
Citation: L. Schaefer et al., DIFFERENTIAL REGULATION OF GLOMERULAR GELATINASE-B (MMP-9) AND TISSUEINHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN OBESE ZUCKER RATS, Journal of the American Society of Nephrology, 8, 1997, pp. 2450-2450
HETEROZYGOSITY FOR FACTOR-V-LEIDEN IN A HEMODIALYSIS PATIENT WITH RECURRENT SHUNT THROMBOSIS
Authors: BREMER C SCHAEFER RM
Citation: C. Bremer et Rm. Schaefer, HETEROZYGOSITY FOR FACTOR-V-LEIDEN IN A HEMODIALYSIS PATIENT WITH RECURRENT SHUNT THROMBOSIS, Nephrology, dialysis, transplantation, 12(8), 1997, pp. 1775-1776
EFFICACY AND SAFETY OF SUSTAINED-RELEASE ALFUZOSIN 5 MG IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
Authors: BUZELIN JM ROTH S GEFFRIAUDRICOUARD C DELAUCHECAVALLIER MC COULANGE C DELMAS V JACQUMIN D JUNG JL HODE E TENAILLON M TOUBOL J DELAERE PJ CORBUSIER A DJURHUNS JC NERSTROM B HERZIG J HENKE G GROTHUESMAN H WEGE B KUTSCHER KR KOCHS K TIETZE M ALBRECHT J SCHONHERR G QUAST D VARDAKIS G PREISS H BASSIRI AM KUHN E PILASKI K WINKLER WP KNUPFER E WULSCH E MATZ HJ WULFF HJ WITTKOWSKY K SCHUTT W SIMON J BOHM G COORS H WIDJAJA F SIEGMUND H SCHMIDT JM KRAUSE U ENGELS KG BRICKENKAMP A HEISING J SCHAEFER RM NELLES P
Citation: Jm. Buzelin et al., EFFICACY AND SAFETY OF SUSTAINED-RELEASE ALFUZOSIN 5 MG IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, European urology, 31(2), 1997, pp. 190-198
DIFFERENTIAL REGULATION OF GLOMERULAR GELATINASE-B (MMP-9) AND TISSUEINHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN OBESE ZUCKER RATS
Authors: SCHAEFER L HAN X AUGUST C MATZKIES F LORENZ T SCHAEFER RM
Citation: L. Schaefer et al., DIFFERENTIAL REGULATION OF GLOMERULAR GELATINASE-B (MMP-9) AND TISSUEINHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN OBESE ZUCKER RATS, Diabetologia, 40(9), 1997, pp. 1035-1043
ALTERATIONS OF CATHEPSIN-B, CATHEPSIN-H AND CATHEPSIN-L IN PROXIMAL TUBULES FROM POLYCYSTIC KIDNEYS (HAN-SPRDRAT)
Authors: SCHAEFER L HAN X GRETZ N SCHAEFER RM
Citation: L. Schaefer et al., ALTERATIONS OF CATHEPSIN-B, CATHEPSIN-H AND CATHEPSIN-L IN PROXIMAL TUBULES FROM POLYCYSTIC KIDNEYS (HAN-SPRDRAT), Journal of the American Society of Nephrology, 7(9), 1996, pp. 1866-1866
ROLE OF LYSOSOMAL CATHEPSIN ACTIVITIES IN CELL HYPERTROPHY INDUCED BYNH4CL IN CULTURED RENAL PROXIMAL TUBULE CELLS
Authors: LING H VAMVAKAS S GEKLE M SCHAEFER L TESCHNER M SCHAEFER RM HEIDLAND A
Citation: H. Ling et al., ROLE OF LYSOSOMAL CATHEPSIN ACTIVITIES IN CELL HYPERTROPHY INDUCED BYNH4CL IN CULTURED RENAL PROXIMAL TUBULE CELLS, Journal of the American Society of Nephrology, 7(1), 1996, pp. 73-80
HOW TO DIAGNOSE AND CORRECT IRON-DEFICIENCY DURING RHUEPO THERAPY - ACONSENSUS REPORT
Authors: HORL WH CAVILL I MACDOUGALL IC SCHAEFER RM SUNDERPLASSMANN G
Citation: Wh. Horl et al., HOW TO DIAGNOSE AND CORRECT IRON-DEFICIENCY DURING RHUEPO THERAPY - ACONSENSUS REPORT, Nephrology, dialysis, transplantation, 11(2), 1996, pp. 246-250
TREATMENT WITH ERYTHROPOIETIN AND LOSS OF DIALYZER CLEARANCE
Authors: SCHAEFER RM SCHAEFER L
Citation: Rm. Schaefer et L. Schaefer, TREATMENT WITH ERYTHROPOIETIN AND LOSS OF DIALYZER CLEARANCE, Nephrology, dialysis, transplantation, 11, 1996, pp. 81-82
LOW-DENSITY-LIPOPROTEIN SUPPRESSES CATHEPSIN-B AND CATHEPSIN-L ACTIVITY IN RAT MESANGIAL CELLS
Authors: PACZEK L TESCHNER M SCHAEFER RM LAO M GRADOWSKA L HEIDLAND A
Citation: L. Paczek et al., LOW-DENSITY-LIPOPROTEIN SUPPRESSES CATHEPSIN-B AND CATHEPSIN-L ACTIVITY IN RAT MESANGIAL CELLS, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 51-53
PROTEIN RESTRICTION INFLUENCES GLOMERULAR MATRIX TURNOVER AND TUBULARHYPERTROPHY BY MODULATION OF RENAL PROTEINASE ACTIVITIES
Authors: SCHAEFER L MEIER K HAFNER C TESCHNER M HEIDLAND A SCHAEFER RM
Citation: L. Schaefer et al., PROTEIN RESTRICTION INFLUENCES GLOMERULAR MATRIX TURNOVER AND TUBULARHYPERTROPHY BY MODULATION OF RENAL PROTEINASE ACTIVITIES, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 162-167
EFFECTS OF PARATHYROID-HORMONE ON RENAL TUBULAR PROTEINASES
Authors: SCHAEFER L MALCHOW M SCHAEFER RM LING H HEIDLAND A MASSRY SG
Citation: L. Schaefer et al., EFFECTS OF PARATHYROID-HORMONE ON RENAL TUBULAR PROTEINASES, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 182-186
ALTERATIONS OF CATHEPSIN-B, CATHEPSIN-H AND CATHEPSIN-L IN PROXIMAL TUBULES FROM POLYCYSTIC KIDNEYS OF THE HAN-SPRD RAT
Authors: SCHAEFER L HAN X GRETZ N SCHAEFER RM
Citation: L. Schaefer et al., ALTERATIONS OF CATHEPSIN-B, CATHEPSIN-H AND CATHEPSIN-L IN PROXIMAL TUBULES FROM POLYCYSTIC KIDNEYS OF THE HAN-SPRD RAT, Kidney international, 50(2), 1996, pp. 424-431
TUBULAR GELATINASE-A (MMP-2) AND ITS TISSUE INHIBITORS IN POLYCYSTIC KIDNEY-DISEASE IN THE HAN-SPRD RAT
Authors: SCHAEFER L HAN X GRETZ N HAFNER C MEIER K MATZKIES F SCHAEFER RM
Citation: L. Schaefer et al., TUBULAR GELATINASE-A (MMP-2) AND ITS TISSUE INHIBITORS IN POLYCYSTIC KIDNEY-DISEASE IN THE HAN-SPRD RAT, Kidney international, 49(1), 1996, pp. 75-81
TUBULAR GELATINASE A (MMP-2) AND ITS TISSUE INHIBITORS IN POLYCYSTIC KIDNEY-DISEASE (PKD)
Authors: SCHAEFER L GRETZ N MATZKIES F SCHAEFER RM
Citation: L. Schaefer et al., TUBULAR GELATINASE A (MMP-2) AND ITS TISSUE INHIBITORS IN POLYCYSTIC KIDNEY-DISEASE (PKD), Journal of the American Society of Nephrology, 6(3), 1995, pp. 709-709
ANGIOTENSIN-II-INDUCED CELL HYPERTROPHY - POTENTIAL ROLE OF IMPAIRED PROTEOLYTIC ACTIVITY IN CULTURED LLC-PK1 CELLS
Authors: LING H VAMVAKAS S SCHAEFER L SCHNITTLER HJ SCHAEFER RM HEIDLAND A
Citation: H. Ling et al., ANGIOTENSIN-II-INDUCED CELL HYPERTROPHY - POTENTIAL ROLE OF IMPAIRED PROTEOLYTIC ACTIVITY IN CULTURED LLC-PK1 CELLS, Nephrology, dialysis, transplantation, 10(8), 1995, pp. 1305-1312
ROLE OF PROTEINASES IN RENAL HYPERTROPHY AND MATRIX ACCUMULATION
Authors: SCHAEFER L LORENZ T DAEMMRICH J HEIDLAND A SCHAEFER RM
Citation: L. Schaefer et al., ROLE OF PROTEINASES IN RENAL HYPERTROPHY AND MATRIX ACCUMULATION, Nephrology, dialysis, transplantation, 10(6), 1995, pp. 801-807
ANTIHYPERTENSIVE TREATMENT WITH A VASODILATING BETA-BLOCKER, CARVEDILOL, IN CHRONIC-HEMODIALYSIS PATIENTS
Authors: DEETJEN A HEIDLAND A PANGERL A MEYERSABELLEK W SCHAEFER RM
Citation: A. Deetjen et al., ANTIHYPERTENSIVE TREATMENT WITH A VASODILATING BETA-BLOCKER, CARVEDILOL, IN CHRONIC-HEMODIALYSIS PATIENTS, Clinical nephrology, 43(1), 1995, pp. 47-52
DOSE-DEPENDENT STIMULATION-INHIBITION EFFECTS OF CYCLOSPORINE-A ON LYSOSOMAL CATHEPSIN ACTIVITIES IN CULTURED PROXIMAL TUBULE CELLS
Authors: LING H VAMVAKAS S SCHAEFER L SCHRAMM L PACZEK L DAEMMRICH J SCHAEFER RM HEIDLAND A
Citation: H. Ling et al., DOSE-DEPENDENT STIMULATION-INHIBITION EFFECTS OF CYCLOSPORINE-A ON LYSOSOMAL CATHEPSIN ACTIVITIES IN CULTURED PROXIMAL TUBULE CELLS, Research in experimental medicine, 195(6), 1995, pp. 355-364
THE HYPOCHROMIC RED-CELL - A NEW PARAMETER FOR MONITORING OF IRON SUPPLEMENTATION DURING RHEPO THERAPY
Authors: SCHAEFER RM SCHAEFER L
Citation: Rm. Schaefer et L. Schaefer, THE HYPOCHROMIC RED-CELL - A NEW PARAMETER FOR MONITORING OF IRON SUPPLEMENTATION DURING RHEPO THERAPY, Journal of perinatal medicine, 23(1-2), 1995, pp. 83-88
Risultati: 1-25 | 26-47